Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025)
Aurora Cannabis (ACB) posted quarterly Non-Current Deferred Tax Liability of $2.5 million for Q4 2025, up 269.28% year-on-year from $675761.6 in Q4 2024, and down 1.37% on a QoQ basis from $2.5 million in Q3 2025.
Aurora Cannabis (ACB) Non-Current Deferred Tax Liability (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Non-Current Deferred Tax Liability for 8 consecutive years, with $2.5 million the latest figure, recorded in Q4 2025.
- Quarterly Non-Current Deferred Tax Liability rose 269.28% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (up 269.28% YoY) and the FY2025 annual result came in at $1.4 million, up 1194.95% from the prior year.
- Non-Current Deferred Tax Liability fell to $2.5 million in Q4 2025 per ACB's latest filing, from $2.5 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for ACB reached as high as $30.5 million in Q1 2023 and fell as low as $105380.1 in Q1 2024.
- A 5-year average of $9.5 million and a median of $11.4 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability sank 99.65% — and 2025, when it surged 1154.55%.
- Year by year, Non-Current Deferred Tax Liability stood at $24.1 million in 2021, then sank by 49.93% to $12.1 million in 2022, then slipped by 0.62% to $12.0 million in 2023, then sank by 94.37% to $675761.6 in 2024, then surged by 269.28% to $2.5 million in 2025.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $2.5 million, $2.5 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 675,761.59 |
| Dec 31, 2024 | 675,761.59 |
| Sep 30, 2024 | 11.37 Mn |
| Sep 30, 2024 | 11.37 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Jun 30, 2024 | 12.86 Mn |
| Mar 31, 2024 | 105,380.08 |
| Mar 31, 2024 | 105,380.08 |
| Dec 31, 2023 | 11.99 Mn |
| Dec 31, 2023 | 11.99 Mn |
| Sep 30, 2023 | 12.36 Mn |
| Sep 30, 2023 | 12.36 Mn |